We use cookies for a better user experience. Read our Privacy Policy

I Agree

Acute Kidney Injury Treatment Market Insights, 2019-2027

Acute Kidney Injury Treatment Market (Treatment: Dialysis and Supportive Care; Type: Prerenal Acute Kidney Injury, Postrenal Acute Kidney Injury, and Intrinsic Renal Acute Kidney Injury; and End-user: Hospitals, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027

Acute Kidney Injury (AKI) Treatment Market: Number of Candidate Drugs Increasing 

Increasing geriatric population, susceptible to acute kidney injury (AKI), has created pressure on researchers and scientists to develop appropriate treatment and therapeutics. Currently, there are around 40 candidate drugs, meant for acute kidney injury treatment, and most of them are in their final stage of approval. The increasing patient pool is another factor that makes the acute kidney injury treatment market a highly lucrative proposition. Considering the evolutions in this landscape, and the possibilities of substantial opportunities, Transparency Market Research, in its new study, offers a 360 degree analysis on the key factors likely to influence market growth. 

Evolution of Acute Kidney Injury (AKI) Treatment 

Acute kidney injury, formerly known as acute renal failure, emerged as a prominent disease after the Second World War. Since then, more emphasis has been laid on the types of therapeutics that need to be developed that can effectively treat this ailment. Alkaline phosphatase, gemigliptin, and QPI002 are few therapeutics that are under clinical trial for treating AKI. As research on acute kidney injury gains momentum, new opportunities are likely to emerge. Influenced by a host of multi-pronged factors, the market for acute kidney injury treatment is likely to surpass a valuation of US$ 2.5 billion by the end of 2027. 

acute kidney injury treatment market strategy

Identify the key factors that will drive your company’s growth. Request a brochure of this report here 

The Therapeutic Landscape 

Adoption of AKI Biomarkers 

The adoption of advanced technologies plays a vital role in enhancing healthcare services. Currently, treatment provided for acute kidney injury is undergoing substantial changes, as researchers are using advanced new tools, predictive models, and biomarkers to improve dialysis procedures and stymie development of acute kidney injuries at an early stage. Emphasis is given on risk stratification along with AKI biomarkers that will enhance overall treatment. 

Ultrasound Technique - A Traditional Break Through 

Introduction of new ultrasound techniques is expected to provide better treatment for acute kidney injuries and chronic kidney diseases. As ultrasound technique is non-invasive, cost-effective, and offers simple imaging modality, it has opened new avenues for monitoring, diagnosis, and treating acute kidney injury. Ultrasound is capable of reducing the effect of AKI by encouraging the splenic cholinergic anti-inflammatory pathway. Further developments are also being made to enhance sensitivity and specificity of ultrasound that will result in providing precise results of diagnosing kidney disease. 

acute kidney injury treatment market north america

Want to know more such detailed insights of Acute Kidney Injury Treatment Market? Request a PDF sample here

Market Players Collaborating with Research Institutes to Develop Effective Drugs 

Researchers are engaged in studying different therapeutics that can be considered to treat AKI. Recently, researchers from the University of Alabama at Birmingham School of Medicine (UAB) and University of California San Diego School of Medicine received grants to enrich the skills especially for kidney diseases. The focus of the center is to evaluate kidney injury and function to improve diagnosis through several biomarkers. They also aim to identify targets for intervention and benefit in decision-making for physicians that will help in better management of patients with kidney diseases. Stakeholders in the acute kidney injury treatment market are keeping an eye on the results of these findings, as research and development remains a key success differentiator in this market. The go-to market strategies in this landscape are heavily influenced by the successful outcomes of research and development, and a substantial pie of the overall revenue share of stakeholders is spent on new product development. Therefore, industry-institution collaboration is likely to remain a norm rather than the exception in this market. 

Vendors are making significant investments in research and development activities to develop drugs and treatment options for acute kidney injury. As mentioned earlier, as of now, there is no particular drug available in the market to treat AKI; therefore, research institutions and market participants are collaborating to develop drugs effective to treat acute kidney injury. At present, there are approx. 40 candidate drugs for AKI in different stages of development. Recently, Alloksys Life Sciences has developed therapeutic RESCAP®. This therapeutic drug is based on Alkaline Phosphatase (AP), a naturally available protein in the body. The aim of this therapeutic is to maintain Blood Brain Barrier (BBB), Kidney Glomerulus Barrier (KGB), Gut Barrier (GB), Lung Alveolar Barrier (LAB), and Placental Barrier (PB). 

Expanding operations in future? To get the perfect launch ask for a custom report here

Moreover, LG Chem is also engaged in extensive research and development activities related to acute kidney injury treatment. LG Chem’sZemiglo is currently undergoing a clinical trial, and after gaining approval, it can be used to treat patients suffering from acute kidney injury. The development of these drugs will be beneficial for players, service providers, and patients. Market players will be capable of establishing themselves in a much profound manner, as most of drugs are in the final stage of approval. Hospitals and patients (end consumer) will also benefit largely from these developments. As the demand for specific drugs will be high in hospitals, and it can benefit both, the manufacturer and the hospital. 

Mergers and Acquisitions: A Key Strategy 

North America, led by the US, continues to be one of the leading markets for acute kidney injury treatment in the US. Leading companies are headquartered in this region, which makes it a prime location for research and development in this landscape. The presence of key players engaged in the development of novel drugs has meant that opportunities for manufacturers are high in the US and Canada as compared to markets where fewer companies are involved in research and development. The availability of new acute kidney injury products, such as QPI-1002 and Zemiglo along with innovative techniques are acting as a key contributor for market’s growth. Moreover, a large number of dialysis centers are present in the region (nearly 6,500 dialysis facilities in the United States alone, as per data by the National Kidney Foundation). 

Mergers and acquisitions are another key strategy used by market players operating in the global acute kidney injury market. Recently, Fresenius Medical Care acquired 70% share of Chinese kidney hospitals and dialysis clinics - Guangzhou KangNiDaiSi Medical Investment Co., Ltd., mainly to expand its dialysis care network and to tap huge patient with kidney injury in this region. This acquisition will also trigger the development of dialysis centers with enhanced services in China. According to the Chinese Society of Nephrology, there are about 500,000 patients in China currently undergoing dialysis. This makes China the biggest market globally after the United States in terms of numbers. 

Prevalence of acute kidney injury has grown substantially in Asia Pacific region--according to various studies, in South-East Asia, the AKI incidence was up to 18%~24% due to rising prevalence of malaria, leptospirosis, gastrointestinal tract infection, and monsoon climate. Moreover, in China the AKI incidence, misdiagnosis, and mortality rates were 1%-2%, 74.2%, and 12.4% respectively among hospitalized patients (2015). Thus, growing incidence of AKI has made government to develop supportive policies to treat acute kidney injury. 

Governments in various countries are introducing supportive policies to spread awareness and provide better facilities to treat AKI. Higher prevalence of chronic kidney diseases (CKD) and growing interest in nephrology led to the initiation of The Kidney Disease Screening and Awareness Program (KDSAP) developed by Harvard College. A few years back, the Indian government started the National Dialysis Programme, under the National Health mission, an initiative of the Ministry of Health and Family Welfare. This initiative was carried out with the help of public-private partnerships at various hospitals. The aim was to provide life-saving procedure close by for patients, and to minimize the burden created by high medical costs. 

acute kidney injury treatment market segmentation

Analysts’ Point of View 

The authors of this report have a positive outlook on the growth of the acute kidney injury treatment market. Increasing number of dialysis centers equipped with state-of-the-art technology is expected to further offer growth opportunities in the acute kidney injury treatment market. Moreover, emphasis on research and development activities to develop drugs for acute kidney injury treatment by players as well as research institutes is set to ensure the growth of this market. With many candidate drugs and novel therapies gaining importance, first-mover companies will have the advantage of gaining a stronger hold in the acute kidney injury treatment market. 

Governments across the globe are also making significant efforts to spread awareness about acute kidney injury treatment. Report authors project that the acute kidney injury treatment market will grow at healthy CAGR of more than 7% between 2019 and 2027 due to the fact that, the prevalence of kidney diseases is considerable around the world.

 

Global Acute Kidney Injury Treatment Market: Overview

  • The global acute kidney injury treatment market is growing, propelled by the increasing prevalence of chronic diseases such as diabetes, hypertension, etc., across the globe.
  • The global acute kidney injury treatment market was valued US$ 1,351.70 Mn in 2018. The global acute kidney injury treatment market is expected to witness a cumulative annual growth rate (CAGR) of more than 7% from 2019 to 2027, to reach a value of more than US$ 2,500 Mn by 2027.

Global Acute Kidney Injury Treatment Market: Drivers & Restraints

  • The global acute kidney injury treatment market is undergoing relatively higher growth, owing to the increasing geriatric patient population, increase in incidences of acute kidney injury cases, and rise in research and development in both, developed and developing markets.
  • The geriatric population has been increasing, especially in developed countries such as the U.S., most countries in Western Europe, and Japan. Developed countries have high geriatric population vis-à-vis their developing counterparts. This can be ascribed to the improved healthcare infrastructure, favorable reimbursement policies, and advancements in healthcare facilities in developed countries. Moreover, access to various diagnostic and treatment services has improved off late, especially in developed countries. This, in turn, has increased the life expectancy of the population. Studies indicate that, a majority (60%-70%) of the elderly population is more susceptible to acute kidney injury. This is a key factor driving the acute kidney injury treatment market.
  • Around 13.3 million people across the globe are estimated to be affected by acute kidney injury. The patient population is expected to rise substantially over the next few decades. Rise in the incidence rate of acute kidney injury is creating a significant socioeconomic impact across the globe.
  • According to the World Health Organization, the world’s population of people aged 60 years and above is expected to reach more than 2 billion, and that of people aged 80 years and above is likely to reach approximately 400 million by 2050.
  • Also, factors such as increase in the number of dialysis centers and strong ongoing clinical pipeline are uplifting the growth of the global acute kidney injury treatment market. However, the disappointing result of promising pipeline molecules is expected to restraint the growth of the global acute kidney injury treatment market.

Global Acute Kidney Injury Treatment Market: Segmentation

  • The global acute kidney injury treatment market is broadly segmented into four categories based on treatment, type, end user, and region.
  • In terms of treatment, the acute kidney injury treatment market is categorized into dialysis and supportive care.
  • Supportive care is used to prevent or treat the symptoms of a disease, or side effects caused by the treatment of a disease. It is also called comfort care, palliative care, and symptom management. Supportive care in acute kidney injury treatment includes the correction of electrolyte, fluid management, acid base abnormalities, hematological abnormalities, and medical management.
  • Based on type, the acute kidney injury treatment market has been classified into prerenal acute kidney injury, postrenal acute kidney injury, and intrinsic renal acute kidney injury. The prerenal acute kidney injury segment held a significant share of the acute kidney injury treatment market in 2018. It is expected to expand at a notable CAGR during the forecast period, led by the prevalence of prerenal acute kidney injuries.
  • Based on end user, the acute kidney injury treatment market has been segregated into hospitals, ambulatory surgical centers, and others.

Global Acute Kidney Injury Treatment Market: Regional Scenario

  • Geographically, the global acute kidney injury treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to be a key region in the global acute kidney injury treatment market, and account for a prominent share of the global acute kidney injury treatment market.
  • North America
  • The acute kidney injury treatment market in the North America is primarily driven by an increase in the patient population, high incidences and prevalence of chronic diseases, and rising research and development, along with a rise in the number of dialysis centers.
  • Europe
  • The acute kidney injury treatment market in Europe is likely to grow at a significant CAGR from 2019 to 2027. Strong ongoing clinical pipeline, presence of key players in the acute kidney injury treatment market in countries such as the Germany, and increase in the number of critical care admissions are expected to boost the growth of the acute kidney injury treatment market in this region.
  • Asia Pacific
  • The acute kidney injury treatment market in Asia Pacific is expected to witness high growth during the forecast period. Rapid growth rate in this region is expected due to the presence of a large base of the geriatric population, governmental initiatives taken to improve the healthcare sector, growth in research and development activities, and increasing patient population with acute kidney injuries in the region.

Global Acute Kidney Injury Treatment Market: Major Players

  • Rising approvals from government bodies, strong sales and distribution networks, increasing number of technological advancements, rising number of acquisitions and mergers, and increasing research and development are the key trends in the global acute kidney injury treatment market.

Key players operating in global acute kidney injury treatment market and profiled in this report are Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem.

Key Segments in the Global Acute Kidney Injury Treatment Market Report

Importance to various segments has been given in the global acute kidney injury treatment market report. Thus, a detailed breakdown of the type, end-user, and treatment takes up a significant share in this report. In this section, segmentation of the acute kidney injury treatment market based on type, treatment, end user, and region is provided.

Type

  • Prerenal Acute Kidney Injury
  • Postrenal Acute Kidney Injury
  • Intrinsic Renal Acute Kidney Injury

Treatment

  • Dialysis
  • Supportive Care

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Region

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East and Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of acute kidney injury treatment market?

Acute kidney injury treatment market to surpass a valuation of US$ 2.5 billion by the end of 2027

What is the anticipated CAGR of the acute kidney injury treatment market in the forecast period?

Acute kidney injury treatment market is projected to expand at a CAGR of more than 7% from 2019 to 2027

What are the key driving factors for the growth of the acute kidney injury treatment market?

Acute kidney injury treatment market is driven by increase in the geriatric population and rising incidences of acute kidney injuries

What are the end-use segments in the acute kidney injury treatment market?

The end-use segments in acute kidney injury treatment market are hospitals and ambulatory surgical centers

Who are the key players in the global acute kidney injury treatment market?

Key players operating in global acute kidney injury treatment market are Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG

    1. Preface 
        1.1. Report Scope and Market Segmentation 
        1.2. Research Highlights
    2. Assumptions and Research Methodology 
        2.1. Assumptions and Acronyms Used
        2.2. Research Methodology
    3. Executive Summary
        3.1. Global Acute Kidney Injury Treatment Market: Market Snapshot
    4. Market Overview
        4.1. Global Acute Kidney Injury Treatment Market: Overview 
        4.2. Global Acute Kidney Injury Treatment Market: Key Industry Developments
        4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
        4.4. Global Acute Kidney Injury Treatment Market Revenue Projection, 2017–2027
        4.5. Global Acute Kidney Injury Treatment Market Outlook
    5. Market Outlook
        5.1. Acute Kidney Injury Epidemiology: Overview
        5.2. Merger and Acquisition Deals
        5.3. Pipeline Analysis
    6. Global Acute Kidney Injury Treatment Market Analysis, by Treatment
        6.1. Key Findings
        6.2. Introduction
        6.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Treatment
        6.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Treatment
            6.4.1. Dialysis
            6.4.2. Supportive Care
        6.5. Global Acute Kidney Injury Treatment Market Analysis, by Treatment 
    7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, by Type
        7.1. Key Findings
        7.2. Introduction
        7.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Type
        7.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Type
            7.4.1. Prerenal Acute Kidney Injury
            7.4.2. Intrinsic Renal Acute Kidney Injury
            7.4.3. Postrenal Acute Kidney Injury
        7.5. Global Acute Kidney Injury Treatment Market Analysis, by Type
    8. Global Acute Kidney Injury Treatment Market Analysis, by End-user
        8.1. Key Findings
        8.2. Introduction
        8.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by End-user
        8.4. Global Acute Kidney Injury Treatment Market Value Forecast, by End-user
            8.4.1. Hospitals
            8.4.2. Ambulatory Surgical Centers
            8.4.3. Others
        8.5. Global Acute Kidney Injury Treatment Market Analysis, by End-user
    9. Global Acute Kidney Injury Treatment Market Analysis, by Region
        9.1. Global Acute Kidney Injury Treatment Market Scenario, by Country
        9.2. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Region
        9.3. Global Acute Kidney Injury Treatment Market Value Forecast, by Region
            9.3.1. North America
            9.3.2. Europe
            9.3.3. Asia Pacific 
            9.3.4. Latin America
            9.3.5. Middle East & Africa
    10. North America Acute Kidney Injury Treatment Market Analysis
        10.1. Key Findings
        10.2. North America Acute Kidney Injury Treatment Market Overview
        10.3. North America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country
        10.4. North America Acute Kidney Injury Treatment Market Forecast, by Country
            10.4.1. U.S.
            10.4.2. Canada
        10.5. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
        10.6. North America Acute Kidney Injury Treatment Market Forecast, by Treatment
            10.6.1. Dialysis
            10.6.2. Supportive Care
        10.7. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Type
        10.8. North America Acute Kidney Injury Treatment Market Forecast, by Type
            10.8.1. Prerenal Acute Kidney Injury
            10.8.2. Intrinsic Renal Acute Kidney Injury
            10.8.3. Postrenal Acute Kidney Injury
        10.9. North America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
        10.10. North America Acute Kidney Injury Treatment Market Forecast, by End-user
            10.10.1. Hospitals
            10.10.2. Ambulatory surgical centers
            10.10.3. Others
        10.11. North America Acute Kidney Injury Treatment Market Attractiveness Analysis
    11. Europe Acute Kidney Injury Treatment Market Analysis
        11.1. Key Findings
        11.2. Europe Acute Kidney Injury Treatment Market Overview
        11.3. Europe Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
        11.4. Europe Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
            11.4.1. Germany
            11.4.2. U.K.
            11.4.3. France
            11.4.4. Italy
            11.4.5. Spain
            11.4.6. Rest of Europe
        11.5. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
        11.6. Europe Acute Kidney Injury Treatment Market Forecast, by Treatment
            11.6.1. Dialysis
            11.6.2. Supportive Care
        11.7. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Type
        11.8. Europe Acute Kidney Injury Treatment Market Forecast, by Type
            11.8.1. Prerenal Acute Kidney Injury
            11.8.2. Intrinsic Renal Acute Kidney Injury
            11.8.3. Postrenal Acute Kidney Injury
        11.9. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
        11.10. Europe Acute Kidney Injury Treatment Market Forecast, by End-user
            11.10.1. Hospitals
            11.10.2. Ambulatory Surgical Centers
            11.10.3. Others
        11.11. Europe Acute Kidney Injury Treatment Market Attractiveness Analysis
    12. Asia Pacific Acute Kidney Injury Treatment Market Analysis
        12.1. Key Findings
        12.2. Asia Pacific Acute Kidney Injury Treatment Market Overview
        12.3. Asia Pacific Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
        12.4. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
            12.4.1. China
            12.4.2. India
            12.4.3. Japan
            12.4.4. Australia & New Zealand
            12.4.5. Rest of Asia Pacific
        12.5. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
        12.6. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Treatment
            12.6.1. Dialysis
            12.6.2. Supportive Care
        12.7. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Type
        12.8. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Type
            12.8.1. Prerenal Acute Kidney Injury
            12.8.2. Intrinsic Renal Acute Kidney Injury
            12.8.3. Postrenal Acute Kidney Injury
        12.9. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
        12.10. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by End-user
            12.10.1. Hospitals
            12.10.2. Ambulatory Surgical Centers
            12.10.3. Others
        12.11. Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis
    13. Latin America Acute Kidney Injury Treatment Market Analysis
        13.1. Key Findings
        13.2. Latin America Acute Kidney Injury Treatment Market Overview
        13.3. Latin America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
        13.4. Latin America Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
            13.4.1. Brazil
            13.4.2. Mexico
            13.4.3. Rest of Latin America
        13.5. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
        13.6. Latin America Acute Kidney Injury Treatment Market Forecast, by Treatment
            13.6.1. Dialysis
            13.6.2. Supportive Care
        13.7. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Type
        13.8. Latin America Acute Kidney Injury Treatment Market Forecast, by Type
            13.8.1. Prerenal Acute Kidney Injury
            13.8.2. Intrinsic Renal Acute Kidney Injury
            13.8.3. Postrenal Acute Kidney Injury
        13.9. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
        13.10. Latin America Acute Kidney Injury Treatment Market Forecast, by End-user
            13.10.1. Hospitals
            13.10.2. Ambulatory Surgical Centers
            13.10.3. Others
        13.11. Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis
    14. Middle East & Africa Acute Kidney Injury Treatment Market Analysis
        14.1. Key Findings
        14.2. Middle East & Africa Acute Kidney Injury Treatment Market Overview
        14.3. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region
        14.4. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
            14.4.1. GCC Countries
            14.4.2. South Africa
            14.4.3. Rest of Middle East and Africa
        14.5. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
        14.6. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Treatment
            14.6.1. Dialysis
            14.6.2. Supportive Care
        14.7. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Type
        14.8. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Type
            14.8.1. Prerenal Acute Kidney Injury
            14.8.2. Intrinsic Renal Acute Kidney Injury
            14.8.3. Postrenal Acute Kidney Injury
        14.9. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
        14.10. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by End-user
            14.10.1. Hospitals
            14.10.2. Ambulatory Surgical Centers
            14.10.3. Others
        14.11. Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis
    15. Competition Landscape
        15.1. Acute Kidney Injury Treatment Market Share Analysis, by Company, 2016
        15.2. Competition Matrix
        15.3. Company Profiles
            15.3.1. Angion Biomedica Corp
                15.3.1.1. Company Details
                15.3.1.2. Business Overview
                15.3.1.3. Financial Overview
                15.3.1.4. Strategic Overview
                15.3.1.5. SWOT Analysis
            15.3.2. AM-Pharma
                15.3.2.1. Company Details
                15.3.2.2. Business Overview
                15.3.2.3. Financial Overview
                15.3.2.4. Strategic Overview
                15.3.2.5. SWOT Analysis
            15.3.3. Quark Pharmaceuticals, Inc
                15.3.3.1. Company Details
                15.3.3.2. Business Overview
                15.3.3.3. Financial Overview
                15.3.3.4. Strategic Overview
                15.3.3.5. SWOT Analysis
            15.3.4. Baxter International, Inc.
                15.3.4.1. Company Details
                15.3.4.2. Business Overview
                15.3.4.3. Financial Overview
                15.3.4.4. Strategic Overview
                15.3.4.5. SWOT Analysis
            15.3.5. Fresenius Medical Care AG & Co. KGaA
                15.3.5.1. Company Details
                15.3.5.2. Business Overview
                15.3.5.3. Financial Overview
                15.3.5.4. Strategic Overview
                15.3.5.5. SWOT Analysis
            15.3.6. LG Chem
                15.3.6.1. Company Details
                15.3.6.2. Business Overview
                15.3.6.3. Financial Overview
                15.3.6.4. Strategic Overview
                15.3.6.5. SWOT Analysis
            15.3.7. Asahi Kasei Medical Co., Ltd
                15.3.7.1. Company Details
                15.3.7.2. Business Overview
                15.3.7.3. Financial Overview
                15.3.7.4. Strategic Overview
                15.3.7.5. SWOT Analysis
            15.3.8. B. Braun Melsungen AG
                15.3.8.1. Company Details
                15.3.8.2. Business Overview
                15.3.8.3. Financial Overview
                15.3.8.4. Strategic Overview
                15.3.8.5. SWOT Analysis

 

List of Tables
Table 01: Acute Kidney Injury Treatment Market Merger and Acquisition Deals 
Table 02: Acute Kidney Injury Treatment Market Merger and Acquisition Deals 
Table 03: AKI Pipeline Analysis
Table 04: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 05: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2027
Table 06: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 07: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 08: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 09: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2027
Table 10: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 11: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 12: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2027
Table 14: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 15: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 16: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2027
Table 18: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 19: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 20: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2027
Table 22: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 23: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 24: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2027
Table 26: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2027
Table 27: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global Acute Kidney Injury Treatment Market Revenue Projection (US$ Mn), 2017–2027
Figure 03: Global Acute Kidney Injury Treatment Market Value Share, by Treatment, 2018
Figure 04: Global Acute Kidney Injury Treatment Market Value Share, by Region, 2018
Figure 05: Global Acute Kidney Injury Treatment Market Value Share, by Type, 2018
Figure 06: Global Acute Kidney Injury Treatment Market Value Share, by End-user, 2018
Figure 07: Global Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 08: Global Acute Kidney Injury Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 09: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Dialysis, 2017–2027
Figure 10: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Supportive Care, 2017–2027
Figure 11: Global Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2018 and 2027
Figure 12: Global Acute Kidney Injury Treatment Market Attractiveness, by Type, 2019–2027
Figure 13: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Prerenal Acute Kidney Injury, 2017–2027
Figure 14: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Intrinsic Renal Acute Kidney Injury, 2017–2027
Figure 15: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Postrenal Acute Kidney Injury, 2017–2027
Figure 16: Global Acute Kidney Injury Treatment Market Value Share, by End-user, 2018 and 2027
Figure 17: Global Acute Kidney Injury Treatment Market Attractiveness, by End-user, 2019–2027
Figure 18: Global Acute Kidney Injury Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2027
Figure 19: Global Acute Kidney Injury Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2017–2027
Figure 20: Global Acute Kidney Injury Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016-2026
Figure 21: Global Acute Kidney Injury Treatment Market Value Share, by Region, 2018 and 2027 
Figure 22: Global Acute Kidney Injury Treatment Market Attractiveness, by Region, 2019–2027
Figure 23: North America Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 24: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Country, 2018 and 2027
Figure 25: North America Acute Kidney Injury Treatment Market Attractiveness, by Country, 2019–2027
Figure 26: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2018 and 2027
Figure 27: North America Acute Kidney Injury Treatment Market Attractiveness, by Type, 2019–2027
Figure 28: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 29: North America Acute Kidney Injury Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 30: North America Acute Kidney Injury Treatment Market Value Share, by End-user, 2018 and 2027
Figure 31: North America Acute Kidney Injury Treatment Market Attractiveness, by End-user, 2019–2027
Figure 32: Europe Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 33: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 34: Europe Acute Kidney Injury Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 35: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2018 and 2027
Figure 36: Europe Acute Kidney Injury Treatment Market Attractiveness, by Type, 2019–2027
Figure 37: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 38: Europe Acute Kidney Injury Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 39: Europe Acute Kidney Injury Treatment Market Value Share, by End-user, 2018 and 2027
Figure 40: Europe Acute Kidney Injury Treatment Market Attractiveness, by End-user, 2019–2027
Figure 41: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 42: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 43: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 44: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2018 and 2027
Figure 45: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness, by Type, 2019–2027
Figure 46: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 47: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 48: Asia Pacific Acute Kidney Injury Treatment Market Value Share, by End-user, 2018 and 2027
Figure 49: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness, by End-user, 2019–2027
Figure 50: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 51: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 52: Latin America Acute Kidney Injury Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 53: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2018 and 2027
Figure 54: Latin America Acute Kidney Injury Treatment Market Attractiveness, by Type, 2019–2027
Figure 55: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 56: Latin America Acute Kidney Injury Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 57: Latin America Acute Kidney Injury Treatment Market Value Share, by End-user, 2018 and 2027
Figure 58: Latin America Acute Kidney Injury Treatment Market Attractiveness, by End-user, 2019–2027
Figure 59: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
Figure 60: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region,
Figure 61: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 62: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2018 and 2027
Figure 63: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness, by Type, 2019–2027
Figure 64: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 65: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 66: Middle East & Africa Acute Kidney Injury Treatment Market Value Share, by End-user, 2018 and 2027
Figure 67: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness, by End-user, 2019–2027
Figure 68: Baxter International, Inc. Breakdown of Net Sales, by Region, 2018
Figure 69: Baxter International, Inc. R&D Intensity and Sales & Marketing Intensity - Company Level (US$ Mn), 2016–2018
Figure 70: Baxter International, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 71: Baxter International, Inc. Breakdown of Net Sales, by Business Segment, 2018
Figure 72: Fresenius Medical Care AG & Co. KGaA Breakdown of Net Sales, by Region, 2016
Figure 73: Fresenius Medical Care AG & Co. KGaA R&D Intensity and Sales & Marketing Intensity - Company Level (US$ Mn), 2016–2018
Figure 74: Fresenius Medical Care AG & Co. KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 75: Fresenius Medical Care AG & Co. KGaA Breakdown of Net Sales, by Business Segment (Health Care Services), 2018

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

729

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved